Related Experiment Video
Updated: Jul 7, 2026

Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model
Published on: April 6, 2022
Current understanding of fungal microflora in inflammatory bowel disease pathogenesis
David Underhill1, Jonathan Braun
1Department of Pathology and Laboratory Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California 90095, USA.
Abstract:
Inflammatory bowel diseases are a current and growing public health problem, with a prevalence that appears to be increasing in most countries and cultures. While most research into the triggering phenomenon has focused on the interaction between commensal bacteria and inflammatory bowel disease, enteric fungi may also be important in determining disease susceptibility. Herein we review what is known about enteric fungi and the mechanisms by which they and their dysregulation might be involved in triggering inflammatory diseases of the bowel.
Insights
Inflammatory bowel diseases (IBD) are a growing public health concern. This review explores the role of enteric fungi, beyond bacteria, in IBD susceptibility and disease development.
Area of Science:
- Gastroenterology
- Immunology
- Microbiology
Background:
- Inflammatory bowel diseases (IBD) represent a significant and increasing global health burden.
- Current research primarily investigates the role of gut bacteria in IBD pathogenesis.
- The potential contribution of the gut mycobiome to IBD remains underexplored.
Purpose of the Study:
- To review the current understanding of enteric fungi in the context of inflammatory bowel diseases.
- To explore the mechanisms by which fungal dysbiosis may influence IBD susceptibility.
- To highlight the importance of considering fungi in IBD research.
Main Methods:
- Comprehensive literature review of studies on enteric fungi and IBD.
- Analysis of proposed mechanisms linking fungal dysregulation to bowel inflammation.
- Synthesis of existing knowledge on the gut mycobiome and IBD.
Main Results:
- Enteric fungi are a component of the gut microbiome and their composition can be altered in IBD patients.
- Fungal dysbiosis may contribute to IBD through various mechanisms, including immune system modulation and barrier function disruption.
- Specific fungal species and their metabolites have been implicated in promoting or exacerbating inflammation.
Conclusions:
- Enteric fungi, in addition to bacteria, are likely involved in the pathogenesis of inflammatory bowel diseases.
- Fungal dysregulation represents a potential therapeutic target for IBD.
- Further research is warranted to elucidate the precise roles of specific fungi in IBD.
Related Concept Videos
Inflammatory Bowel Disease III: Crohn's Disease
Dysbiosis of the Gut Microbiota
Inflammatory Bowel Disease II: Ulcerative Colitis
Inflammatory Bowel Disease I: Introduction
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...

